Phio Pharmaceuticals Corp. (PHIO)

NASDAQ: PHIO · Real-Time Price · USD

1.900

+0.090 (4.97%)

At close: May 13, 2025, 4:00 PM

1.860

-0.040 (-2.10%)

Pre-market: May 14, 2025, 8:20 AM EDT

Phio Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cost of Revenue	3.64	6.33	7.01	8.89	3.72	Upgrade
Gross Profit	-3.64	-6.33	-7.01	-8.89	-3.72	Upgrade
Selling, General & Admin	3.74	4.37	4.45	4.63	5.08	Upgrade
Operating Expenses	3.74	4.37	4.45	4.63	5.08	Upgrade
Operating Income	-7.39	-10.7	-11.46	-13.51	-8.79	Upgrade
Interest Expense	-	-0.01	-	-	-0	Upgrade
Interest & Investment Income	0.23	-	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0.01	0.01	-0.02	-0.01	-	Upgrade
EBT Excluding Unusual Items	-7.15	-10.7	-11.48	-13.52	-8.79	Upgrade
Asset Writedown	-	-0.13	-	-	-	Upgrade
Other Unusual Items	-	-	-	0.23	-	Upgrade
Pretax Income	-7.15	-10.83	-11.48	-13.29	-8.79	Upgrade
Net Income	-7.15	-10.83	-11.48	-13.29	-8.79	Upgrade
Net Income to Common	-7.15	-10.83	-11.48	-13.29	-8.79	Upgrade
Shares Outstanding (Basic)	1	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	1	0	0	0	0	Upgrade
Shares Change (YoY)	240.15%	83.32%	6.30%	179.70%	-	Upgrade
EPS (Basic)	-9.08	-46.76	-90.91	-111.84	-207.04	Upgrade
EPS (Diluted)	-9.08	-46.76	-90.91	-111.87	-207.04	Upgrade
Free Cash Flow	-7.11	-10.75	-12.25	-11.91	-8.82	Upgrade
Free Cash Flow Per Share	-9.03	-46.45	-97.00	-100.24	-207.68	Upgrade
EBITDA	-7.39	-10.64	-11.39	-13.44	-8.72	Upgrade
D&A For EBITDA	0	0.06	0.07	0.08	0.07	Upgrade
EBIT	-7.39	-10.7	-11.46	-13.51	-8.79	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q